ATE140798T1 - Lipid-abhängige diagnostische analysenverfahren - Google Patents

Lipid-abhängige diagnostische analysenverfahren

Info

Publication number
ATE140798T1
ATE140798T1 AT91902056T AT91902056T ATE140798T1 AT E140798 T1 ATE140798 T1 AT E140798T1 AT 91902056 T AT91902056 T AT 91902056T AT 91902056 T AT91902056 T AT 91902056T AT E140798 T1 ATE140798 T1 AT E140798T1
Authority
AT
Austria
Prior art keywords
assay
phospholipid
suspension
sample
lipid
Prior art date
Application number
AT91902056T
Other languages
English (en)
Inventor
Andrew S Janoff
Joyce Rauch
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ATE140798T1 publication Critical patent/ATE140798T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT91902056T 1990-12-07 1990-12-28 Lipid-abhängige diagnostische analysenverfahren ATE140798T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62334090A 1990-12-07 1990-12-07

Publications (1)

Publication Number Publication Date
ATE140798T1 true ATE140798T1 (de) 1996-08-15

Family

ID=24497709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91902056T ATE140798T1 (de) 1990-12-07 1990-12-28 Lipid-abhängige diagnostische analysenverfahren

Country Status (10)

Country Link
EP (1) EP0561780B1 (de)
JP (1) JP2983630B2 (de)
AT (1) ATE140798T1 (de)
AU (1) AU648775B2 (de)
CA (1) CA2095928C (de)
DE (1) DE69027936T2 (de)
DK (1) DK0561780T3 (de)
ES (1) ES2090306T3 (de)
GR (1) GR3021412T3 (de)
WO (1) WO1992010586A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
RU2239197C1 (ru) * 2003-01-23 2004-10-27 Межрегиональная благотворительная общественная организация инвалидов "Общество больных гемофилией" Способ определения волчаночного антикоагулянта
JP4377207B2 (ja) * 2003-11-28 2009-12-02 シスメックス株式会社 血液凝固時間測定方法および血液凝固時間測定用試薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543339A (en) * 1982-03-16 1985-09-24 Oneill Christopher Early pregnancy detection by detecting enhanced blood platelet activation
US4698299A (en) * 1985-02-19 1987-10-06 The Liposome Company, Inc. Lipid-dependent diagnostic assays
US4666831A (en) * 1985-02-19 1987-05-19 The Liposome Company, Inc. Lipid-dependent diagnostic assays
EP0303515B1 (de) * 1987-08-13 1992-11-11 Synbiotics Corporation Bestimmungen einer amphipathischen Substanz durch Verwendung einer lipophilen Oberfläche
US4877741A (en) * 1988-10-24 1989-10-31 The United States Of America As Represented By The Secretary Of The Air Force Treatment of human plasma with brown recluse spider toxin to emulate a lupus anticoagulant

Also Published As

Publication number Publication date
DK0561780T3 (da) 1996-12-09
CA2095928C (en) 1999-08-31
EP0561780A1 (de) 1993-09-29
JP2983630B2 (ja) 1999-11-29
JPH06503640A (ja) 1994-04-21
EP0561780A4 (de) 1994-08-03
AU7162091A (en) 1992-07-08
EP0561780B1 (de) 1996-07-24
DE69027936T2 (de) 1997-03-06
ES2090306T3 (es) 1996-10-16
GR3021412T3 (en) 1997-01-31
CA2095928A1 (en) 1992-06-08
DE69027936D1 (de) 1996-08-29
WO1992010586A1 (en) 1992-06-25
AU648775B2 (en) 1994-05-05

Similar Documents

Publication Publication Date Title
SE8008952L (sv) Forfarande och anordning for bestemning av serumlipoproteiner
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
ES2153030T3 (es) Procedimiento de analisis cuantitativo del colesterol.
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
EP0030388A3 (de) Verfahren zum Nachweis und zur Mengenbestimmung von okkultem Blut in einer menschlichen Probe
FI842189A0 (fi) Testanordning.
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
WO2000026668A3 (en) S100 proteins and autoantibodies as serum markers for cancer
ATE107418T1 (de) Nachweis von analyt in partikel enthaltenden proben.
Takikawa et al. Usefulness and accuracy of the international normalized ratio and activity percent of prothrombin time in patients with liver disease
ATE140798T1 (de) Lipid-abhängige diagnostische analysenverfahren
ES2067024T3 (es) Metodo y kit para determinar actividades fosforilantes y desfosforilantes de tirosina.
Wood et al. Reproducibility of serological titers
MXPA02012176A (es) Un metodo para detectar un complejo de liproproteina -proteina de fase aguda y predecir un riesgo mayor de falla de sistema o mortalidad.
DK0525149T3 (da) Amylinaktivitetsassays
Rubin et al. Accuracy of three dry-chemistry methods for lipid profiling and risk factor classification
Liu et al. Immunochemical determination of LDH-1
Elyas et al. Valproic acid estimation by enzyme immunoassay
ATE242487T1 (de) Verfahren zur bestimmung von schilddrüsen- autoantikörpern
Cobbaert et al. Different effects of Intralipid and triacylglycerol rich lipoproteins on Kodak Ektachem serum cholesterol determination
Hoffmann et al. Serological distance coefficients
US3733398A (en) Determining and reversing anticomplementary activity in complement fixation test for australia antigen
Freudenrich et al. The effects of adrenalectomy on the alpha-adrenergic regulation of cytosolic free calcium in hepatocytes.
Edelman et al. Evaluation of the new Beckman electrophoretic method for CK-MB: comparison with ion exchange chromatography and investigation of a reference outpatient population
EP0615128A2 (de) Vorrichtung und Test zur Bestimmung eines Antigens oder eines Antikörpers in einer Testprobe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee